Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
From - Laboratory Industry Report
While Theranos initially set out to change the laboratory sector with its Edison testing platform, to date it has mostly changed…
From - Laboratory Industry Report
Theranos continues to remake itself, shedding its longtime president and expanding its board of directors…
From - Laboratory Industry Report
A new coalition has been formed to push for more laboratory-based allergy testing. The Coalition for Equal Access to Allergy Testing (CEAAT) said it…